HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
IMTX
Immatics N.V.
IMTX lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow, though they disagree widely on how much.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
IMTX Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Strong |
IMTX's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
IMTX PE Valuation
IMTX has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
IMTX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong decline | |
| -- | |
| Limited | |
| Low |
Analysts expect IMTX's losses to grow, with revenue declining. However, they disagree widely on these estimates.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
IMTX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.77 | -$1.15 |
| Q1 2026 | -$1.90 | -$1.73 |
| Q4 2025 | -$1.79 | -1153% |
| Q3 2025 | -$0.97 | -$0.28 |
| Q2 2025 | -$0.62 | +$0.30 |
| Q1 2025 | -$0.17 | +$0.92 |
| Q4 2024 | $0.17 | +$1.51 |
| Q3 2024 | -$0.69 | +$0.50 |
IMTX is still losing money, but far less than before: $1.77 per share over the past year, against $4.09 at its worst in mid-2021.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over IMTX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over IMTX on profitability, with a higher operating margin.
IMTX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $10.2M | +93% |
| Q1 2026 | $8.5M | -59% |
| Q4 2025 | $22M | -65% |
| Q3 2025 | $5.8M | -90% |
| Q2 2025 | $5.3M | -75% |
| Q1 2025 | $20.6M | -39% |
| Q4 2024 | $62.5M | +253% |
| Q3 2024 | $56.2M | +753% |
IMTX's revenue is recovering but still below its 2022 peak: $10M last quarter, up 93% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -735% | +387 points |
| Q1 2026 | -868% | -678 points |
| Q4 2025 | -197% | -198 points |
| Q3 2025 | -1053% | -1054 points |
| Q2 2025 | -1122% | -980 points |
| Q1 2025 | -190% | -146 points |
| Q4 2024 | 1.6% | +176 points |
| Q3 2024 | 1% | +562 points |
IMTX's operating margin was −735% last quarter, up 387 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over IMTX on cash generation, producing positive trailing cash flow while its opponent burns cash.
IMTX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$69M | -$23.8M |
| Q1 2026 | -$48.3M | -$6.9M |
| Q4 2025 | -$65.1M | +$1.8M |
| Q3 2025 | -$50.9M | -$10.3M |
| Q2 2025 | -$45.1M | -$5.1M |
| Q1 2025 | -$41.5M | +$5.2M |
| Q4 2024 | -$66.9M | -186% |
| Q3 2024 | -$40.6M | +$557.7K |
IMTX has burned cash in most quarters: −$233M over the past year, against −$194M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over IMTX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
IMTX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.5% | +2M shares |
| 1 year | +12% | +15.1M shares |
| 3 years | +77% | +59.4M shares |
| 5 years | +117% | +73.8M shares |
| Available history | +117% | +73.8M shares |
IMTX has 137M diluted shares, up 12% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
IMTX hasn't bought back shares in the past year.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
IMTX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | -6.4x | Net Cash |
| Q4 2022 | -3.6x | Net Cash |
| Q3 2022 | -7.9x | Net Cash |
| Q2 2022 | -13.0x | Net Cash |
| Q1 2022 | -20.1x | Net Cash |
IMTX has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
IMTX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 11.5 | Oversold |
IMTX's weekly RSI is 33 (neutral) and its Stochastic is 12 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
IMTX PE vs Healthcare Sector
| Metric | IMTX | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
IMTX has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
IMTX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.19 | 9.3% below |
| 20 week MA | $8.45 | 23% below |
| 50 week MA | $9.48 | 31% below |
| 100 week MA | $7.91 | 18% below |
| 200 week MA | $9.15 | 29% below |
IMTX is in a downtrend: it's below all five of its weekly moving averages, and 29% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
IMTX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.4 | $9.99 | -3.9% |
| 2021 | $9.99 | $13.0 | +30% |
| 2022 | $13.0 | $8.51 | -34% |
| 2023 | $8.51 | $10.5 | +24% |
| 2024 | $10.5 | $7.13 | -32% |
| 2025 | $7.13 | $10.2 | +43% |
| 2026 YTD | $10.2 | $6.52 | -36% |
IMTX has the edge over HIMS on returns for 2026, with the stronger performance.